4 BIORX

Modern Healthcare - - HEALTHCARE’S HOTTEST -

WHAT IT DOES:

Pro­vides and dis­trib­utes spe­cialty medicine and clin­i­cal and in-home sup­port ser­vices for the treat­ment of he­mophilia, AAT de­fi­ciency, se­vere nu­tri­tional de­fi­cien­cies and other af­flic­tions.

HOW IT GREW:

A quick scan of BioRx’s re­cent ac­tiv­ity shows a com­pany ag­gres­sively ex­pand­ing, both ac­quir­ing new busi­nesses and pre­mier­ing new prod­ucts and ser­vices for its cus­tomers. In July, BioRx ac­quired Coag­ulife Phar­macy, which fo­cuses on pre­ven­tive phys­i­cal ther­apy for he­mophilia pa­tients, which the com­pany says is of­fered al­most nowhere else in the U.S.

BioRx’s re­cent flurry of ac­tiv­ity speaks to its com­mit­ment to serv­ing its spe­cial­ized cor­ner of health­care and its de­sire to re­main at the fore­front of the surg­ing spe­cialty phar­ma­ceu­ti­cal in­dus­try, of­fi­cials say. Ac­cord­ing to the 2012 Spe­cialty Drug Ben­e­fit Re­port re­leased by the Phar­macy Ben­e­fit Man­age­ment In­sti­tute, spend­ing on spe­cialty medicine has in­creased 15% to 20% over the past sev­eral years and is expected to continue to out­pace non­spe­cialty spend­ing in the fu­ture.

Lo­ca­tion: Cincin­nati Top ex­ec­u­tive: Co-Founder and Pres­i­dent

Philip Rielly Num­ber of em­ploy­ees: 169 An­nual rev­enue (2011): $114.6 mil­lion Rev­enue growth (2006-11): 636.3% Web­site: biorx.com

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.